Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Public ClinicalTrials.gov record NCT07228026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Combined Prospective, Multicenter, Non-Randomized, Open-Label, Point-of-Care and Home Use Pivotal Study of the fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Non-Steroid-Treated Adult and Pediatric Uncontrolled Asthma Subjects and a Prospective Multicenter Clinical Precision Evaluation for Point-of-Care and Home Use in Adult and Pediatric Controlled Asthma Subjects
Study identification
- NCT ID
- NCT07228026
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Biometry Inc
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- fenoTRACK Device Device
Device
Eligibility (public fields only)
- Age range
- 5 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 16, 2025
- Primary completion
- Sep 29, 2026
- Completion
- Sep 29, 2026
- Last update posted
- Mar 23, 2026
2025 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bensch Clinical Research LLC | Stockton | California | 95207 | Recruiting |
| AllerVie Clinical Research | Panama City | Florida | 32405 | Active, not recruiting |
| AllerVie Clinical Research | Columbus | Georgia | 31904 | Recruiting |
| Paul A Shapero MD | Bangor | Maine | 04401 | Recruiting |
| AllerVie Clinical Research | Ellicott City | Maryland | 21043 | Recruiting |
| AllerVie Clinical Research | Glenn Dale | Maryland | 20769 | Recruiting |
| Nebraska Medical Research Institute, Inc. | Bellevue | Nebraska | 68123-4303 | Recruiting |
| Allergy Partners Clinical Research | Asheville | North Carolina | 28803 | Recruiting |
| Toledo Institute of Clinical Research Inc | Toledo | Ohio | 43617 | Recruiting |
| Orion Clinical Research | Austin | Texas | 78759 | Recruiting |
| Pharmaceutical Research & Consulting, Inc. | Dallas | Texas | 75231 | Recruiting |
| Western Sky Medical Research | El Paso | Texas | 79912 | Recruiting |
| Allergy, Asthma & Sinus Center, S.C. | Greenfield | Wisconsin | 53228 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07228026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2026 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07228026 live on ClinicalTrials.gov.